论文信息 - LBA45 Randomized open label phase III study comparing the efficacy and safety of everolimus followed by chemotherapy (CT) with streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs: The SEQTOR study (GETNE 1206) - 字舞流文

LBA45 Randomized open label phase III study comparing the efficacy and safety of everolimus followed by chemotherapy (CT) with streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs: The SEQTOR study (GETNE 1206)

A. Colao | J. Metges | R. García-Carbonero | C. Carnaghi | J. Capdevila | R. Salazar | S. Tafuto | L. Vestermark | H. Klumpen | I. Sevilla | N. Reed | J. Hernando | V. Valenti | M. Krogh | V. Navarro | B. Cremer | B. Eriksson | E. Tabaksblat | A. Teule | J. Schrader | V. Valentí